A recent Canadian study reveals that older adults hospitalized for respiratory syncytial virus (RSV) face heightened risks of ...

Despite near universal availability of nirsevimab, only 35% of eligible children receive nirsevimab for RSV prophylaxis.

GSK is taking to the airwaves to get the message out about respiratory syncytial virus (RSV), presenting a TV special about how the pathogen has affected athletes in the upcoming National Senior Games ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

Appointments will continue to be issued over the next couple of weeks and pregnant women who are 28-week-plus are also ...

A single shot during pregnancy is proving to be a powerful shield for newborns against one of the most common and dangerous viruses for infants: RSV. In a new UK study, babies whose mothers received t ...

Respiratory syncytial virus (RSV) infections in older adults lead to significantly more severe health outcomes and long-term cardiovascular complications compared to other common causes of ...

CDC panel, reshaped by RFK Jr., rejects thimerosal flu shots and backs RSV drug amid resignations, expert criticism and ...

Adults over 50 and those with chronic conditions are at risk too. Learn how to protect yourself and where to go for more information.